World

Vaccination against syncytial virus starts on September 16

The pediatric vaccination campaign against respiratory syncytial virus runs until March 31, 2027, covering all infants.

3 September 2026Tagblick Newsdesk

AI-generatedWritten by an AI system, editorially responsible — how we work

Vaccination against syncytial virus starts on September 16 — Photo: Governo do Estado de São Paulo · Wikimedia Commons · CC BY 2.0

The Directorate-General for Health (DGS) announced the start of the seasonal pediatric vaccination campaign against respiratory syncytial virus (RSV), which will begin on September 16. This initiative aims to protect children and reduce the transmission of the virus during the time of year when its circulation intensifies.

According to the DGS, all infants will be eligible for vaccination, a measure intended to minimize the risks associated with RSV, which can cause severe respiratory infections in young children.

The vaccination campaign is expected to last until March 31, 2027, thus providing an extended period of protection for the pediatric population. The DGS hopes that participation in the campaign will be high, contributing to public health.

The vaccination process will be organized in health centers and other health units, where parents can take their children to be vaccinated. The DGS will provide additional information about logistics and specific vaccination locations as the start date approaches.

This announcement has been widely covered by various media outlets, including Observador and RTP, which highlighted the importance of vaccination in preventing respiratory illnesses in children.

The campaign raises awareness about the need for childhood vaccination and the impact of RSV on public health, reiterating the DGS's commitment to protecting the most vulnerable groups in the population.

This item was written by an AI system on the basis of the headlines and short teasers of the independently operating newsrooms named below. We disclose this under Art. 50(4), second subparagraph, of Regulation (EU) 2024/1689 (AI Act). Before publication we check origin and verifiability — anything that appears in only one place is not published — as well as language, substance and legally sensitive content. No separate substantive review of each individual item by a natural person takes place; we therefore do not rely on the exemption in Art. 50(4), second subparagraph, of the AI Act. Editorial responsibility for this publication rests with the person named in the imprint (§ 18 Abs. 2 MStV). Please report errors to [email protected] — we will correct or remove the item. Full reports are available from the sources listed.